Peripheral

Peripheral solutions that increase your imaging and therapy options

Datele de contact

* Acest câmp este obligatoriu
*
*
*
*
*
*
*
*
*
Înapoi
Specifică-ne motivul pentru care doreşti să ne contactezi pentru a-ţi putea fi cât mai de folos
*
*
Înapoi

Philips announces the acquisition of CardioProlific Inc.

 

Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced the acquisition of CardioProlific Inc., a US-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease.

Philips is the leader in image guided therapy and committed to working with health care providers to improve treatment for every patient. Our seamless integrated solutions advance minimally invasive procedures by helping clinicians to decide, guide, treat and confirm the right therapy for each patient at the point of care.

Below you can view the currently available peripheral products, related technologies, and a compatibility chart with Philips Core systems.

Peripheral

Compatibility with Philips systems and technologies

IntraSight

IntraSight

Interventional applications platform
Core/Core Mobile

Core/Core Mobile

Precision guided therapy system
Excimer Laser System

Excimer Laser System

CVX-300 & 300p

Peripheral imaging catheters

  • Visions .014P
  • Visions .018
  • Visions .035
  • Visions .014P
  • Visions .018
  • Visions .035
  • -

Re-entry system

  • Pioneer Plus
  • Pioneer Plus
  • -

Technologies

  • ChromaFlo (Visions .014P, Visions .018, and Pioneer Plus only)
  • IVUS
  • VH IVUS (PV .014P only)*
  • ChromaFlo (Visions .014P, Visions .018, and Pioneer Plus only)
  • IVUS
  • VH IVUS (PV .014P only)*
  • -

Atherectomy

  • -
  • -
  • Turbo-Power laser atherectomy catheter
  • Turbo-Elite laser atherectomy catheter
  • Turbo-Tandem laser guide catheter with laser atherectomy catheter

Resources

Downloadable iOS app

*Safety and effectiveness of VH IVUS for use in the characterization of vascular lesions and tissue types has not been established.